Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Novel Application of a Multistate Model to Evaluate the Opioid Use Disorder Care Cascade: A Retrospective Cohort Study

View ORCID ProfileAnarina L. Murillo, Tianyu Sun, View ORCID ProfileHilary Aroke, Jeffrey Bratberg, Stephen Kogut, Brandon D.L. Marshall, Jesse L. Yedinak, Josiah D. Rich, Rebecca Lebeau, Joseph W. Hogan, Ashley Buchanan
doi: https://doi.org/10.1101/2022.03.10.22271924
Anarina L. Murillo
1Department of Biostatistics, New York University, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anarina L. Murillo
Tianyu Sun
2Department of Pharmacy and Practice, University of Rhode Island, Kingston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilary Aroke
2Department of Pharmacy and Practice, University of Rhode Island, Kingston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hilary Aroke
Jeffrey Bratberg
2Department of Pharmacy and Practice, University of Rhode Island, Kingston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Kogut
2Department of Pharmacy and Practice, University of Rhode Island, Kingston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon D.L. Marshall
3Department of Epidemiology, Brown University School of Public Health, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesse L. Yedinak
3Department of Epidemiology, Brown University School of Public Health, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josiah D. Rich
3Department of Epidemiology, Brown University School of Public Health, Providence, RI
4Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Lebeau
5Department of Psychology, University of Rhode Island, Kingston, RI
6Executive Office of Health and Human Services, State of Rhode Island, Cranston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph W. Hogan
7Department of Biostatistics, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Buchanan
2Department of Pharmacy and Practice, University of Rhode Island, Kingston, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: buchanan{at}uri.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Evaluating the opioid use disorder (OUD) care cascade can improve OUD treatment retention and care.

Objectives To identify risk and protective factors for retention among patients in OUD treatment.

Methods We conducted a retrospective cohort study among patients diagnosed with OUD using data from the Rhode Island (RI) All-Payer Claims Database from 2011 to 2019. Patients who initiated treatment (Stage 2) were classified into sub-stages of retention (Stage 3) corresponding to multistate modeling states capturing early retention (sub-stage 1), short and long-term retention (sub-stage 2), and short and long-term disengagement (sub-stage 3). The association of baseline characteristics with state transitions were evaluated.

Results A cohort of 6,939 RI residents diagnosed with OUD included 41% aged 40 to 60 years, 57.6% male, and 70.8% Medicaid beneficiaries. In sub-stage 1, cannabis (Relative risk ratios (RRR) = 1.16; 95% confidence interval (CI) = 1.04,1.29) and cocaine use disorders (RRR=1.15; 95% CI=1.05,1.25) increased early disengagement risk after engagement. Medicaid beneficiaries were less likely to experience early disengagement (RRR=0.81; 95% CI =0.76,0.87). In sub-stage 2, alcohol (RRR=1.29; 95% CI=1.13,1.47) or cocaine use disorders (RRR=1.18; 95% CI=1.01,1.40) increased risk of disengagement among patients in the retention states. In sub-stage 3, tobacco (RRR=1.10; 95% CI=1.01,1.21) and alcohol (RRR=1.14; 95% CI=1.03,1.27) use disorders were associated with re-engagement from disengaged states.

Conclusion The multistate model applied to a cohort of patients initiating medication for OUD led to the identification of factors associated with treatment engagement and retention. These results may guide strategies to sustain treatment among OUD patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The project described was supported by Award Number 1DP2DA046856-01 from the National Institute on Drug Abuse of the National Institutes of Health, Institutional Development Award Number U54GM115677 and P20-GM125507 from the National Institute of General Medical Sciences of the National Institutes of Health (NIGMS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/IRB of Brown University gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding: The project described was supported by Award Number 1DP2DA046856-01 from the National Institute on Drug Abuse of the National Institutes of Health. Drs. Ashley Buchanan and Stephen Kogut were partially supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health (NIGMS), which funds Advance Clinical and Translational Research (Advance-CTR). Dr. Marshall, Dr. Rich, and Ms. Yedinak were also supported by the NIGMS (P20-GM125507). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • Disclosures: The authors report no relevant disclosures.

Data Availability

All data produced in the present study are available upon reasonable request to Brown University.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted March 12, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Novel Application of a Multistate Model to Evaluate the Opioid Use Disorder Care Cascade: A Retrospective Cohort Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Novel Application of a Multistate Model to Evaluate the Opioid Use Disorder Care Cascade: A Retrospective Cohort Study
Anarina L. Murillo, Tianyu Sun, Hilary Aroke, Jeffrey Bratberg, Stephen Kogut, Brandon D.L. Marshall, Jesse L. Yedinak, Josiah D. Rich, Rebecca Lebeau, Joseph W. Hogan, Ashley Buchanan
medRxiv 2022.03.10.22271924; doi: https://doi.org/10.1101/2022.03.10.22271924
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Novel Application of a Multistate Model to Evaluate the Opioid Use Disorder Care Cascade: A Retrospective Cohort Study
Anarina L. Murillo, Tianyu Sun, Hilary Aroke, Jeffrey Bratberg, Stephen Kogut, Brandon D.L. Marshall, Jesse L. Yedinak, Josiah D. Rich, Rebecca Lebeau, Joseph W. Hogan, Ashley Buchanan
medRxiv 2022.03.10.22271924; doi: https://doi.org/10.1101/2022.03.10.22271924

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (428)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3285)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13347)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5139)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14618)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4912)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (204)